Equity in Access

Supporting the generation of evidence that will guide changes in healthcare policy and practice to ensure that all patients with and survivors of a blood cancer achieve access to the cancer care and services they need throughout their lives.

HCL2025 guidelines

The HCLF and LLS joining forces to expanding research in Hairy Cell Leukemia to better characterize its biology, develop new therapies, and optimize outcomes for patients.

Download the 2019 Request For Proposals or
view our Statement on Future Research and Therapies for HCL.

The LLS Children’s Initiative Latest News

The LLS Children’s Initiative is a $100 million multi-year effort to take on children’s cancer through every facet of our mission: Research, Patient Education and Support and Policy and Advocacy.

LLS PedAL: Precision Medicine for Children with Leukemia

As part of The LLS Children’s Initiative, LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision medicine master clinical trial to match children with relapsed acute leukemia to a targeted therapy based on the specific abnormalities driving their cancer.

Study in Nature Medicine Shows Superior Outcomes for Patients in LLS's Paradigm-Shifting Beat AML Clinical Trial

Bringing Precision Medicine to AML patients:
LLS’S Beat AML® Master Clinical Trial